Invest in intelligence that delivers

Ocrevus Use Still Growing in Europe But Challenges on Horizon, Spherix Reports

From: Multiple Sclerosis News Today

By: Marta Figueiredo

Multiple Sclerosis News Today

Prescriptions of Roche’s Ocrevus (ocrelizumab) among multiple sclerosis (MS) patients initiating or switching a disease-modifying…

 

Sign up for alerts, market insights and exclusive content in your inbox.